Maravai LifeSciences (MRVI) Tops Q2 EPS by 2c

Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $51.4 million versus the consensus estimate of $48.68 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.

You May Also Be Interested In

• US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
• Strategy (MSTR) call put ratio 2.1 calls to 1 put with a focus on August 28 weekly calls as share price up 5.1%
• MetLife (MET) PT Raised to $106 at Evercore ISI